Adherence to Direct Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation: A Single-Center Retrospective Study
Journal of Cardiovascular Pharmacology and Therapeutics · 2026
DOI: 10.1177/10742484261490639 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, 2026. Verfasst von Cuie Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Dabigatran, Rivaroxaban, Stroke. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Pharmacy Special Committee of Zhejiang Medical Doctor Association, Clinical Medicine Special Fund Project of Zhejiang Medical Association.
Abstract (Originalsprache)
Objective
To investigate adherence to four direct oral anticoagulants (DOACs) and its influencing factors in patients with non-valvular atrial fibrillation (NVAF), providing evidence for strategies to improve adherence.
Methods
A retrospective cohort study included NVAF patients initiating DOAC therapy at a tertiary hospital (January 2016–November 2023). Adherence was evaluated using the proportion of days covered (PDC), with PDC ≥ 0.8 defined as good adherence. Adherence levels for dabigatran, rivaroxaban, apixaban, and edoxaban were compared at 3, 6, 9, and 12 months. Logistic regression identified factors influencing 1-year adherence, assessing the impact of initiation year and the National Volume-Based Drug Procurement (NVBP) policy.
Results
A total of 1,150 NVAF patients were enrolled (dabigatran: n = 401; rivaroxaban: n = 656; apixaban: n = 18; edoxaban: n = 75),In this main cohort, overall adherence progressively declined, with only 40.78% achieving PDC ≥ 0.8 at 1 year. Significant differences existed among groups (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Pharmacy, Zhejiang Hospital, Hangzhou, China.
ORCID-Profile: Junjun Xu
Förderung
- Clinical Pharmacy Special Committee of Zhejiang Medical Doctor Association
- Clinical Medicine Special Fund Project of Zhejiang Medical Association
Zitieren
APA
Chang, C., Lv, S., Yu, L., Xu, L., Xu, D., Dai, H., & Xu, J. (2026). Adherence to Direct Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation: A Single-Center Retrospective Study. Journal of Cardiovascular Pharmacology and Therapeutics. https://doi.org/10.1177/10742484261490639
Vancouver
Chang C, Lv S, Yu L, Xu L, Xu D, Dai H, et al. Adherence to Direct Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation: A Single-Center Retrospective Study. Journal of Cardiovascular Pharmacology and Therapeutics. 2026. doi:10.1177/10742484261490639
BibTeX
@article{Chang2026,
author = {Chang, Cuie and Lv, Sha and Yu, Lingyan and Xu, Lingcheng and Xu, Donghang and Dai, Haibin and Xu, Junjun},
title = {Adherence to Direct Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation: A Single-Center Retrospective Study},
journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
year = {2026},
doi = {10.1177/10742484261490639}
}
EUVIMED